Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes
AssigneeAventis Pharmaceuticals Inc.
InventorsRalf Rosskamp, Hertzel Gerstein
Life of this patent
Estimating the term…
Abstract
This invention relates to a method of reducing cardiovascular morbidity and mortality in a prediabetic or Type 2 Diabetes patient population. The method comprises administering an effective dosage of a long acting insulin, preferably insulin glargine, to a prediabetic or Type 2 Diabetes patient.
Claims48
A method of treating impaired glucose tolerance (IGT) in a patient in need thereof comprising administering an effective dosage of a long acting insulin.
A method of treating impaired fasting glucose (IFG) in a patient in need thereof comprising administering an effective dosage of a long acting insulin.
A method of treating early Type 2 diabetes in a patient in need thereof comprising administering an effective dosage of a long acting insulin.
A method of treating diabetic dyslipidemia in a Type 2 diabetes patient comprising administering an effective dosage of a long acting insulin.
A method of treating atherosclerosis in a patient diagnosed with a disease or condition selected from the group consisting of IFG, IGT, and early Type 2 diabetes, comprising administering an effective dosage of a long acting insulin.
A method of improving endothelial function in a patient diagnosed with a disease or condition selected from the group consisting of IFG, IGT, and early Type 2 diabetes, comprising administering an effective dosage of a long acting insulin.
A method of improving left ventricular diastolic and systolic function in a patient diagnosed with a disease or condition selected from the group consisting of IFG, IGT, and early Type 2 diabetes, comprising administering an effective dosage of a long acting insulin.
A method of reducing blood glucose levels in a patient diagnosed with a disease or condition selected from the group consisting of IFG, IGT, and early Type 2 diabetes, comprising administering an effective dosage of a long acting insulin.
Dependencies are inferred from the claim text.